Ionis Pharmaceuticals (IONS) Inventory Average (2018 - 2026)

Ionis Pharmaceuticals has reported Inventory Average for 9 years, with the latest figure at $7.8 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 35.02% year-over-year to $7.8 million; the trailing twelve-month figure through Mar 2026 stood at $7.8 million (down 35.02% YoY), and the FY2025 full-year result was $11.3 million, up 13.07% from the prior year.
• Inventory Average for Q1 2026 stood at $7.8 million, down from $10.3 million in the prior quarter.
• The five-year high for Inventory Average was $29.5 million in Q2 2024, with the low at $7.8 million in Q1 2026.
• Average Inventory Average over 5 years is $19.0 million, with a median of $20.5 million recorded in 2024.
• Year-over-year, Inventory Average rose 26.49% in 2023 and tumbled 66.85% in 2025.
• Tracing IONS's Inventory Average over 5 years: stood at $21.3 million in 2022, then retreated by 22.5% to $16.5 million in 2023, then gained by 23.85% to $20.5 million in 2024, then slumped by 49.91% to $10.3 million in 2025, then slipped by 23.94% to $7.8 million in 2026.
• The last three Inventory Average figures came in at $7.8 million (Q1 2026), $10.3 million (Q4 2025), and $9.5 million (Q3 2025), per Business Quant data.

Peer Comparison